Literature DB >> 15247151

Transcriptional changes following restoration of SERCA2a levels in failing rat hearts.

Federica Del Monte1, Rishikesh Dalal, Adel Tabchy, Jennifer Couget, Kenneth D Bloch, Randall Peterson, Roger J Hajjar.   

Abstract

Heart failure is characterized at the cellular level by impaired contractility and abnormal Ca2+ homeostasis. We have previously shown that restoration of a key enzyme that controls intracellular Ca(2+) handling, the sarcoplasmic reticulum Ca2+ ATPase (SERCA2a), induces functional improvement in heart failure. We used high-density oligonucleotide arrays to explore the effects of gene transfer of SERCA2a on genetic reprogramming in a model of heart failure. A total of 1,300 transcripts were identified to be unmodified by the effect of virus alone. Of those, 251 transcripts were found to be up- or down-regulated upon failure. A total of 51 transcripts which were either up--(27) or down--(24) regulated in heart failure were normalized to the nonfailing levels by the restoration of SERCA2a by gene transfer. The microarray analysis identified new genes following SERCA2a restoration in heart failure, which will give us insights into their role in the normalization of multiple pathways within the failing cell.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247151     DOI: 10.1096/fj.04-1714fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

Review 1.  Cardiac gene therapy with SERCA2a: from bench to bedside.

Authors:  Judith K Gwathmey; Alexan I Yerevanian; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2010-11-18       Impact factor: 5.000

Review 2.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

3.  AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.

Authors:  Philip W J Raake; Philipp Schlegel; Jan Ksienzyk; Julia Reinkober; Jens Barthelmes; Stefanie Schinkel; Sven Pleger; Walter Mier; Uwe Haberkorn; Walter J Koch; Hugo A Katus; Patrick Most; Oliver J Müller
Journal:  Eur Heart J       Date:  2012-01-19       Impact factor: 29.983

4.  Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression.

Authors:  Xiaodong Zhu; Charles F McTiernan; Navin Rajagopalan; Hemal Shah; David Fischer; Yoshiya Toyoda; Dustin Letts; Jonathan Bortinger; Gregory Gibson; Wenyu Xiang; Kenneth McCurry; Michael Mathier; Joseph C Glorioso; Barry London
Journal:  Hum Gene Ther       Date:  2012-07-11       Impact factor: 5.695

5.  Examining the genomic influence of skin antioxidants in vitro.

Authors:  James V Gruber; Robert Holtz
Journal:  Mediators Inflamm       Date:  2010-07-12       Impact factor: 4.711

Review 6.  Linking Biochemical and Structural States of SERCA: Achievements, Challenges, and New Opportunities.

Authors:  Rodrigo Aguayo-Ortiz; L Michel Espinoza-Fonseca
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.